IBDEI306 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50341,1,4,0)
 ;;=4^M35.09
 ;;^UTILITY(U,$J,358.3,50341,2)
 ;;=^5011791
 ;;^UTILITY(U,$J,358.3,50342,0)
 ;;=M35.04^^219^2447^58
 ;;^UTILITY(U,$J,358.3,50342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50342,1,3,0)
 ;;=3^Sicca Syndrome w/ Tubulo-Interstitial Nephropathy
 ;;^UTILITY(U,$J,358.3,50342,1,4,0)
 ;;=4^M35.04
 ;;^UTILITY(U,$J,358.3,50342,2)
 ;;=^5011790
 ;;^UTILITY(U,$J,358.3,50343,0)
 ;;=M35.00^^219^2447^59
 ;;^UTILITY(U,$J,358.3,50343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50343,1,3,0)
 ;;=3^Sicca Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,50343,1,4,0)
 ;;=4^M35.00
 ;;^UTILITY(U,$J,358.3,50343,2)
 ;;=^5011786
 ;;^UTILITY(U,$J,358.3,50344,0)
 ;;=M32.10^^219^2447^62
 ;;^UTILITY(U,$J,358.3,50344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50344,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec Organ/System Involvement
 ;;^UTILITY(U,$J,358.3,50344,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,50344,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,50345,0)
 ;;=M32.9^^219^2447^61
 ;;^UTILITY(U,$J,358.3,50345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50345,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,50345,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,50345,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,50346,0)
 ;;=M34.2^^219^2447^63
 ;;^UTILITY(U,$J,358.3,50346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50346,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,50346,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,50346,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,50347,0)
 ;;=M34.81^^219^2447^64
 ;;^UTILITY(U,$J,358.3,50347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50347,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,50347,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,50347,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,50348,0)
 ;;=M34.82^^219^2447^65
 ;;^UTILITY(U,$J,358.3,50348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50348,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,50348,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,50348,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,50349,0)
 ;;=M34.83^^219^2447^66
 ;;^UTILITY(U,$J,358.3,50349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50349,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,50349,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,50349,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,50350,0)
 ;;=M34.9^^219^2447^67
 ;;^UTILITY(U,$J,358.3,50350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50350,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,50350,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,50350,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,50351,0)
 ;;=M81.0^^219^2448^18
 ;;^UTILITY(U,$J,358.3,50351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50351,1,3,0)
 ;;=3^Osteoporosis,Age-Related
 ;;^UTILITY(U,$J,358.3,50351,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,50351,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,50352,0)
 ;;=M46.46^^219^2448^2
 ;;^UTILITY(U,$J,358.3,50352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50352,1,3,0)
 ;;=3^Discitis,Lumbar Region,Unspec
 ;;^UTILITY(U,$J,358.3,50352,1,4,0)
 ;;=4^M46.46
 ;;^UTILITY(U,$J,358.3,50352,2)
 ;;=^5012006
 ;;^UTILITY(U,$J,358.3,50353,0)
 ;;=M46.47^^219^2448^3
 ;;^UTILITY(U,$J,358.3,50353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50353,1,3,0)
 ;;=3^Discitis,Lumbosacral Region,Unspec
 ;;^UTILITY(U,$J,358.3,50353,1,4,0)
 ;;=4^M46.47
 ;;^UTILITY(U,$J,358.3,50353,2)
 ;;=^5012007
 ;;^UTILITY(U,$J,358.3,50354,0)
 ;;=J98.6^^219^2448^1
 ;;^UTILITY(U,$J,358.3,50354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50354,1,3,0)
 ;;=3^Diaphragm Disorders
